Quick Answer
Bicara Therapeutics Inc. reported Total Assets of $430.99 million for the year ending 2025.
- Bicara Therapeutics Inc. showed a decrease of -15.5% in Total Assets from 2024 to 2025.
- This data is from Bicara Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2024: $524.17 million | Q1 2025: $478.08 million | Q2 2025: $453.59 million | Q3 2025: $424.69 million.
- Over the full 3 years of available data (2023 to 2025), Bicara Therapeutics Inc.'s Total Assets has grown by 84.2%.
- Historical annual values: Fiscal year 2025: $430.99 million | Fiscal year 2024: $510.00 million | Fiscal year 2023: $233.98 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: